- OT
- View all news
- Trademark dispute over dry eye treatment settled
Trademark dispute over dry eye treatment settled
Ophthalmic product company, threesixty, has issued an apology to The EyeBag Company for the sale of an eye mask that infringed the company’s patent
12 August 2019
A trademark dispute has been settled between ophthalmic product company, threesixty, and the manufacturer of a patented dry eye treatment.
The EyeBag Company issued High Court proceedings against threesixty over the sale of an eye mask containing flax seeds for the treatment of meibomian gland dysfunction.
After the claim was settled out of court for an undisclosed sum, threesixty issued an apology on its website.
The company stated that the warm eye compresses that were sold on its website between 2016 and 2018 had been removed from sale.
When approached for comment by OT, owner of The EyeBag Company, Professor Teifi James, highlighted that the eye bag has become very popular over the past 15 years and some people do not realise that it is a registered trademark; whether written as one word or two, singular or plural.
“All variations of eye bag are protected and covered by the trademark registration in most countries,” he highlighted.
“Other brands of warm compresses are not eye bags,” Professor James added.
“I’m pleased that we were able to arrive at a mutually satisfactory settlement without having to go through the whole court process on this occasion,” he shared.
The settlement is the second legal action that Professor James has taken against a company this year.
Legal action was also brought against a Lancashire company, Wheatybags, for patent and trademark infringements.
Image credit: Pixabay
Advertisement
More News
-
Researchers apply AI to OCT scans and fundus photographs to learn more about systemic health -
Moorfields Eye Charity to invest at least £2 million in eye health research -
Small increase in dry eye disease risk among patients taking statins -
Researchers highlight “growing challenge” of antibiotic resistance in veterinary ophthalmology
Comments (0)
You must be logged in to join the discussion. Log in